Veerhealth Care Limited (BOM:511523)
India · Delayed Price · Currency is INR 27.71
+1.29 (4.88%)
At close: Jun 17, 2026
Veerhealth Care Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 324.85 | 166.71 | 132.23 | 132.73 | 96.26 |
Other Revenue | 8.02 | 6.13 | 9.9 | 9.41 | 11.73 |
| 332.86 | 172.84 | 142.13 | 142.14 | 107.99 | |
Revenue Growth (YoY) | 92.58% | 21.60% | -0.00% | 31.62% | -5.02% |
Cost of Revenue | 241.51 | 115.83 | 92.56 | 94.75 | 71.27 |
Gross Profit | 91.36 | 57.01 | 49.57 | 47.39 | 36.73 |
Selling, General & Admin | 17.14 | 17.04 | 15.38 | 12.87 | 11.79 |
Other Operating Expenses | 41.6 | 29.22 | 18.2 | 20.14 | 21.41 |
Operating Expenses | 71.65 | 55.34 | 40.69 | 39.22 | 38.44 |
Operating Income | 19.7 | 1.66 | 8.88 | 8.17 | -1.72 |
Interest Expense | -4.02 | -0.96 | - | - | -0.45 |
Interest & Investment Income | - | 6.05 | 3.99 | 2.99 | 4.94 |
Other Non Operating Income (Expenses) | - | -1.68 | -0.08 | -0.01 | -0.41 |
EBT Excluding Unusual Items | 15.68 | 5.08 | 12.8 | 11.14 | 2.38 |
Gain (Loss) on Sale of Assets | - | - | 0.02 | 0.03 | - |
Other Unusual Items | -3.1 | - | - | - | - |
Pretax Income | 12.58 | 5.08 | 12.82 | 11.17 | 2.38 |
Income Tax Expense | 7.14 | 1.16 | 8.75 | -4.65 | 3.11 |
Net Income | 5.44 | 3.91 | 4.06 | 15.82 | -0.74 |
Net Income to Common | 5.44 | 3.91 | 4.06 | 15.82 | -0.74 |
Net Income Growth | 38.99% | -3.62% | -74.33% | - | - |
Shares Outstanding (Basic) | 20 | 20 | 20 | 20 | 14 |
Shares Outstanding (Diluted) | 20 | 20 | 20 | 20 | 14 |
Shares Change (YoY) | 0.75% | - | - | 44.20% | - |
EPS (Basic) | 0.27 | 0.20 | 0.20 | 0.79 | -0.05 |
EPS (Diluted) | 0.27 | 0.20 | 0.20 | 0.79 | -0.05 |
EPS Growth | 37.96% | -3.62% | -74.33% | - | - |
Free Cash Flow | -6.65 | -92.02 | 20.7 | -27.85 | 2.25 |
Free Cash Flow Per Share | -0.33 | -4.60 | 1.03 | -1.39 | 0.16 |
Gross Margin | 27.45% | 32.98% | 34.88% | 33.34% | 34.01% |
Operating Margin | 5.92% | 0.96% | 6.25% | 5.75% | -1.59% |
Profit Margin | 1.63% | 2.27% | 2.86% | 11.13% | -0.68% |
Free Cash Flow Margin | -2.00% | -53.24% | 14.56% | -19.59% | 2.08% |
EBITDA | 32.62 | 10.74 | 16 | 14.39 | 3.53 |
EBITDA Margin | 9.80% | 6.21% | 11.25% | 10.12% | 3.26% |
D&A For EBITDA | 12.91 | 9.08 | 7.12 | 6.22 | 5.24 |
EBIT | 19.7 | 1.66 | 8.88 | 8.17 | -1.72 |
EBIT Margin | 5.92% | 0.96% | 6.25% | 5.75% | -1.59% |
Effective Tax Rate | 56.75% | 22.92% | 68.31% | - | 130.98% |
Revenue as Reported | 332.86 | 178.89 | 146.13 | 145.13 | 112.94 |
Advertising Expenses | - | 1.26 | 2.28 | 3.67 | 2.92 |